DCVC Opportunity Fund II GP, LLC — 13F Holdings & Portfolio
CIK 1668343 · latest 13F-HR filed 2026-08-14
DCVC Opportunity Fund II GP, LLC manages $17.2M in 13F-reported U.S. long-equity assets across 2 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are RXRX (84.30%), IONQ (15.70%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 2, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
PALO ALTO, CA 94301
$17.2M
Long-equity book
2
Distinct positions
2026-06-30
Filed 2026-08-14
+0 / −0 / ↑2 / ↓0
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- Recursion Pharmaceuticals, Inc.$2.4M +19.5%
- IonQ, Inc.$964.2K +55.5%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $17.2M | 2 | 0001104659-26-097081 |
| 2026-03-31 | 2026-05-15 | $13.9M | 2 | 0001104659-26-062468 |
| 2025-12-31 | 2026-02-17 | $16.6M | 2 | 0001104659-26-015687 |
| 2025-09-30 | 2025-11-14 | $19.3M | 1 | 0001104659-25-111912 |